0001104659-20-009340.txt : 20200131 0001104659-20-009340.hdr.sgml : 20200131 20200131170047 ACCESSION NUMBER: 0001104659-20-009340 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200130 FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ANDERSON RICHARD ALLAN CENTRAL INDEX KEY: 0001266647 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37704 FILM NUMBER: 20565790 MAIL ADDRESS: STREET 1: 11111 SANTA MONIKA BLVD STE.550 CITY: LOS ANGELES STATE: CA ZIP: 90025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DarioHealth Corp. CENTRAL INDEX KEY: 0001533998 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 452973162 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 HATOKHEN ST. CITY: CAESAREA STATE: L3 ZIP: 38900 BUSINESS PHONE: (972)-(3)-6222929 MAIL ADDRESS: STREET 1: 8 HATOKHEN ST. CITY: CAESAREA STATE: L3 ZIP: 38900 FORMER COMPANY: FORMER CONFORMED NAME: LabStyle Innovations Corp. DATE OF NAME CHANGE: 20111101 4 1 tm206305d1_4.xml OWNERSHIP DOCUMENT X0306 4 2020-01-30 0 0001533998 DarioHealth Corp. DRIO 0001266647 ANDERSON RICHARD ALLAN 8 HATOKHEN STREET CAESAREA INDUSTRIAL PARK L3 3088900 ISRAEL 0 1 0 0 President, GM of North America Employee Stock Option (right to buy) 8.41 2020-01-30 4 A 0 90000 A 2026-01-30 Common Stock 90000 90000 D Employee Stock Option (right to buy) 8.41 2020-01-30 4 A 0 90000 A Common Stock 90000 90000 D The option was granted on January 30, 2020 and provides for vesting as follows: (i) 30,000 shares of common stock vest on first anniversary of the date of grant; and (ii) 60,000 shares of common stock vest in equal quarterly installment during the two year period following the first anniversary of the date of grant, subject to the Reporting Person's continued employment by the company. The option vests over a three years period commencing on the first day of the relevant following fiscal year, in twelve (12) equal quarterly installments, upon the Company's attainment for each fiscal year ending December 31, 2020 through December 31, 2023, of specified business to business revenues recognized by the Company in the United States, subject in each case to the Reporting Person's continued employment by the company on the applicable vesting date. /s/ Richard Anderson 2020-01-31